Possibly — but there are few reports. 80% of 10 people who reported on Tirzepatide for blood sugar say it improved. 10% noticed no change and 10% say it got worse.
Conclusion: This study shows that new anti-diabetic drugs, particularly GLP1-RA and Tirzepatide, are the most effective in inducing weight loss in patients with type 2 diabetes. Interestingly, exenatide appears to be the only GLP1-RA that induces a mild weight loss.
Conclusion: Our data show that s.c. tirzepatide had a more pronounced effect on HbA1c and weight reduction compared with s.c. semaglutide in people with type 2 diabetes. Both drugs, particularly higher doses of tirzepatide, increased gastrointestinal adverse events.
Based on few reports — treat as anecdotal. Information only — not medical advice. How we count